NCT00830856View on ClinicalTrials.gov

Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa

NACompletedINTERVENTIONAL
Enrollment

54

Participants

Timeline

Start Date

October 31, 2006

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2009

Conditions
Cryptococcal MeningitisHIV Infections
Interventions
DRUG

Fluconazole

Fluconazole 800mg po qday

DRUG

Fixed dose - Stavudine, lamivudine and Nevirapine

Initiation within 72 hours of diagnosis of Cryptococcal meningitis.

DRUG

Fixed dose - Stavudine, Lamivudine, Nevirapine

Delayed initiation of ART defined as 10 weeks after initiation of high dose fluconazole therapy.

Trial Locations (1)

Unknown

University of Zimbabwe, College of Health Sciences, Harare

All Listed Sponsors
collaborator

AIDS Care Research in Africa

OTHER

lead

University of Zimbabwe

OTHER

NCT00830856 - Early Versus Delayed Antiretroviral Therapy (ART) in the Treatment of Cryptococcal Meningitis in Africa | Biotech Hunter | Biotech Hunter